FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,004 letters match. Newest first.

  1. Uriel Pharmacy, Inc.

    Uriel Pharmacy's homeopathic ampule drugs are unapproved new drugs and were made under serious CGMP violations.

    High risk
  2. RNA Bio/Pharma, Incorporated

    FDA found RNA Bio/Pharma failed to test homeopathic oral liquid drugs for dangerous contaminants and did not validate its water system.

    High risk
  3. Miers Laboratories, Ltd

    CGMP/Finished Pharmaceuticals/Adulterated

  4. Taizhou Kangping Medical Science and Technology Co., Ltd.

    CGMP/Finished Pharmaceuticals/Adulterated

  5. Compass Group USA

    CGMP/Food/Prepared, Packed or Held Under Insanitary Conditions/Adulterated/L. monocytogenes

  6. Apotex Inc.

    CGMP/Finished Pharmaceuticals/Adulterated

  7. Liebel-Flarsheim Company LLC

    CGMP/Finished Pharmaceuticals/Adulterated

  8. Scientific Protein Laboratories, LLC

    CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

  9. Kath Khemicals LLC

    CGMP/Finished Pharmaceuticals/Adulterated

  10. The Tranzonic Companies/Innocore Sales & Marketing Inc.

    FDA says Innocore Sales & Marketing, an over-the-counter drug manufacturer, lacked finished-product, component, stability and quality-unit controls.

    High risk
  11. Qianjiang Kingphar Medical Material Co Ltd.

    FDA warned Chinese device maker Qianjiang Kingphar that dirty cleanrooms and weak environmental controls make its masks, dressings, wraps and drapes adulterated.

    High risk
  12. Contec Medical Systems Co., Ltd.

    FDA warns Chinese device maker Contec Medical Systems over quality system failures; its patient monitors and ultrasound devices face US border detention.

    High risk
  13. Royal Philips

    FDA warns Royal Philips over ultrasound device quality-system failures, including complaint handling and transducers distributed past useful life.

    High risk
  14. Acme United Corporation

    Acme United Corporation made antiseptic wipes with contaminated water and released sterile drugs without sterility testing.

    High risk
  15. Foshan Yiying Hygiene Products Co., Ltd.

    Foshan Yiying, a Chinese OTC drug maker, lacked finished-product testing, stability data and process validation; FDA has blocked its imports.

    High risk
  16. Guangxi Yulin Pharmaceutical Group Co. Ltd.

    FDA warned Guangxi Yulin Pharmaceutical Group that its OTC drugs lacked release testing and had data integrity failures.

    High risk
  17. BRS Analytical Services, LLC

    BRS Analytical Services, LLC made sterile OTC drugs in an unsuitable aseptic facility and recalled them over sterility assurance.

    High risk
  18. LEVO AG

    FDA says LEVO AG lacked a quality system, adverse-event reporting procedures, and device ID data for standup wheelchairs.

    High risk
  19. Allovate Therapeutics, LLC

    FDA warned Allovate that its Allerdent allergenic toothpaste is an unapproved drug and lacks a required biologic license.

    High risk
  20. Technological Medical Advancements LLC

    CGMP/QSR/Medical Devices/Adulterated

  21. Naturich Cosmetique Labs

    CGMP/Finished Pharmaceuticals/Adulterated

  22. Creative Essences, Inc.

    FDA warns Creative Essences over OTC drug manufacturing failures and an unapproved antiseptic.

    High risk
  23. New Life Medical Services, LLC

    CGMP/Deviations/Biologics License Application (BLA)

  24. Dixon Investments Inc. dba ARI

    FDA cites Dixon Investments (ARI) for manufacturing-rule and unapproved/misbranded OTC aerosol drug violations.

    High risk
  25. Persōn & Covey, Inc.

    FDA cites Persōn & Covey for CGMP failures at its Glendale, CA drug plant and for selling unapproved Xerac AC and Drysol.

    High risk
  26. Time Challenger Labs International, Inc.

    Time Challenger Labs was warned for unapproved drug claims on five supplements and serious manufacturing violations.

    High risk
  27. Gracie's Kitchens, Inc.

    FDA warns Gracie's Kitchens over Listeria on RTE produce food-contact surfaces and sanitation failures.

    High risk
  28. Tan Nam Corporation

    FDA warned Tan Nam Corporation that its ready-to-eat soybean products were held under insanitary conditions and may be contaminated.

    High risk
  29. Hans Bakery Inc. d/b/a Andersen’s Bakery

    FDA found rodent and insect filth and serious food-safety failures at Hans Bakery's Hayward, CA facility making ready-to-eat bakery items and tuna salad.

    High risk
  30. Valentine Enterprises, Inc.

    FDA warned Valentine Enterprises that its dietary supplements were adulterated by manufacturing violations and misbranded by label errors.

    Medium
  31. Vidaslim Co.

    Vidaslim Co. dietary supplements are adulterated by CGMP failures and misbranded by label violations.

    Medium
  32. Media Networks Sydney Pty. Limited

    FDA says Australia's Media Networks Sydney failed to answer drug records requests for OTC Combantrin Chocolate Squares.

    High risk
  33. Chengdu Brilliant Biopharmaceutical Co., Ltd.

    CGMP/Finished Pharmaceuticals/Adulterated

  34. Janssen Vaccines Corp., A Johnson & Johnson Company

    CGMP/Finished Pharmaceuticals/Adulterated

  35. Columbia Cosmetics Manufacturing Inc.

    CGMP/Finished Pharmaceuticals/Adulterated

  36. Yangzhou Yulou Paper Products Co., Ltd.

    FDA cited Yangzhou Yulou Paper Products for manufacturing violations after records showed its OTC sterile drugs lacked sterility assurance and testing.

    High risk
  37. Somerset Therapeutics Private Limited

    FDA cited Somerset Therapeutics' India plant for CGMP failures tied to a contaminated media fill and aseptic processing risks.

    High risk
  38. Hikal Limited

    FDA warned India's Hikal Limited that unresolved metal-particle complaints in its APIs and weak supplier oversight make its active ingredients adulterated.

    High risk
  39. Amneal Pharmaceuticals, LLC

    FDA warns Amneal over visible particles in ropivacaine injection and inadequate investigations and endotoxin lab controls.

    High risk
  40. Wisconsin Pharmacal Company, LLC

    FDA warns Wisconsin Pharmacal over OTC drug manufacturing violations, including released rejected product and S. aureus contamination.

    High risk
  41. Chromatography Institute of America dba Compounder’s International Analytical Laboratory

    FDA warned Chromatography Institute of America, a Colorado contract drug testing lab, that sterility testing and quality controls violated current good manufacturing practice.

    High risk
  42. Synergy Animal Products, Inc.

    Synergy Animal Products marketed unapproved animal drugs for dairy cows with inadequate directions and major manufacturing violations.

    High risk
  43. Miach Orthopaedics

    FDA warns Miach Orthopaedics over quality-system failures in manufacturing its BEAR ACL Implant, including sterility monitoring and nonconforming product controls.

    High risk
  44. LeMaitre Vascular, Inc.

    LeMaitre Vascular's Artegraft graft plant in New Jersey drew an FDA warning letter for water, sterilization and recall-reporting failures.

    High risk
  45. Uscom Kft

    Uscom Kft marketed SpiroSonic AIR spirometer in the U.S. without FDA clearance and had multiple quality system failures at its Budapest plant.

    High risk
  46. Anhui Hanbon Daily Chemical Co., Ltd.

    CGMP/Finished Pharmaceuticals/Adulterated

  47. Les Encres LLC

    FDA warns Les Encres that its PDO surgical suture threads were promoted for unapproved cosmetic uses and had quality system violations.

    High risk
  48. Chaohu Daxin Foodstuffs Co., Ltd.

    Seafood HACCP/CGMP for Foods/Adulterated

  49. ABBE Laboratories, Inc.

    FDA warns ABBE Laboratories over manufacturing failures for over-the-counter topical drugs, including ingredient testing.

    High risk
  50. Spectra Therapy, LLC

    CGMP/QSR/Medical Devices/Adulterated